Does IXEKIZUMAB Cause Condition aggravated? 376 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 376 reports of Condition aggravated have been filed in association with IXEKIZUMAB (TALTZ). This represents 1.1% of all adverse event reports for IXEKIZUMAB.
376
Reports of Condition aggravated with IXEKIZUMAB
1.1%
of all IXEKIZUMAB reports
1
Deaths
53
Hospitalizations
How Dangerous Is Condition aggravated From IXEKIZUMAB?
Of the 376 reports, 1 (0.3%) resulted in death, 53 (14.1%) required hospitalization, and 1 (0.3%) were considered life-threatening.
Is Condition aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IXEKIZUMAB. However, 376 reports have been filed with the FAERS database.
What Other Side Effects Does IXEKIZUMAB Cause?
Injection site pain (3,799)
Psoriasis (2,818)
Drug ineffective (2,759)
Injection site erythema (2,144)
Injection site reaction (1,701)
Injection site swelling (1,615)
Incorrect dose administered (1,032)
Covid-19 (861)
Product dose omission issue (832)
Therapy interrupted (796)
What Other Drugs Cause Condition aggravated?
TOFACITINIB (16,925)
INFLIXIMAB (16,616)
DUPILUMAB (16,459)
ETANERCEPT (15,897)
METHOTREXATE (14,938)
ADALIMUMAB (13,527)
PREDNISONE (10,751)
INFLIXIMAB-DYYB (10,275)
HYDROXYCHLOROQUINE (8,848)
RITUXIMAB (8,627)
Which IXEKIZUMAB Alternatives Have Lower Condition aggravated Risk?
IXEKIZUMAB vs JAKAFI
IXEKIZUMAB vs JANUMET
IXEKIZUMAB vs JANUVIA
IXEKIZUMAB vs JETREA
IXEKIZUMAB vs JUXTAPID